CannaBiz Invest Asia Draws Global Medical & Industrial Cannabis Industry Players to Bangkok

BANGKOK, July 19, 2019 /PRNewswire/ -- With more Asian countries starting to legalise medical and industrial cannabis use, major cannabis product manufacturers will convene in Bangkok for a timely summit to share insights on this new market.Aurora Cannabis shares insights on Global Cannabis Market Outlook & Investment Landscape. Day 1 also features sessions from cannabis producers a?? CannAcubed presenting a case study on 'China's Industrial Hemp Cultivation & Value Chain Investment' and Elixinol Global providing the 'Growth Outlook for Hemp Foods, Protein & the CBD Market in Japan & Globally'. Coffee break sponsor a?? Medipharm Labs will speak on Australia's Role in APAC Medical Cannabis Market.Other cannabis producers sharing their perspectives are:

Blue Sky Biologicals - Hemp: Beyond CBD & THC, a Whole Plant Model

Hikurangi Cannabis Company - Cannabis Legislation in New Zealand: Reflections on Government Efforts to Design World-Leading Medicinal Cannabis & Full Legalisation

Bombay Hemp Company Private Limited (BOHECO) - Industrial and Medical Cannabis Investment in India a?? Scientific and Legal Perspective

BOL Pharma - From Farm to Pharmaceutical Products a?? Israel's Experience

Thailand - the first Southeast Asian country to legalise cannabis use for medical purposes a?? gathers 2 experts providing details on a?? 'Understanding the Medical Cannabis Investment Landscape & Regulatory Hurdles in Thailand' - Tilleke & Gibbins International and 'Integration of Medical Cannabis in Thai Traditional Medicine - A Balancing Game' - Dept. of Thai Traditional and Alternative Medicine, Ministry of Health.Organised by Centre for Management Technology (CMT), the program also features sessions on:

The Future of Sustainable Fashion & Hemp Fibres Industry - Kingdom Holdings

"Green Green Profits" - The Cultivation of Outdoor Medical Cannabis as a Business Model for Asia - Jacana Holdings

Commercialisation of Plant-Derived Cannabinoid Prescription Medicines to Meet Global Demand - MGC Pharmaceuticals

Pharmaceutical Development in Man-Made Cannabinoids - Akseera Pharma

In addition, MYM Nutraceuticals, Helius Therapeutics and Cannex Capital join a panel discussion on 'Accessing Capital Markets for Cannabis Investments a?? Options & Challenges'.Meet exhibitors Shenzhen Number Energy Saving Corporation and Blue Sky Biologicals among others at the event. For exhibition details, email event website for registration or call +65 6346 9147 for more details.Contact:
Ms. Grace Oh
+65 6346 9147Photos: 
CannaBiz Invest Asia Draws Global Medical & Industrial Cannabis Industry Players to Bangkok
View original content: Centre for Management Technology (CMT)
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Декабрь 2019    »